Comprehensive genomic profiling of breast cancers characterizes germline-somatic mutation interactions mediating therapeutic vulnerabilities.
Chen C, Lin CJ, Pei YC, Ma D, Liao L, Li SY, Fan L, Di GH, Wu SY, Liu XY, Wang YJ, Hong Q, Zhang GL, Xu LL, Li BB, Huang W, Shi JX, Jiang YZ, Hu X, Shao ZM.
Chen C, et al. Among authors: ma d.
Cell Discov. 2023 Dec 19;9(1):125. doi: 10.1038/s41421-023-00614-3.
Cell Discov. 2023.
PMID: 38114467
Free PMC article.